33rd week of 2014 patent applcation highlights part 37 |
Patent application number | Title | Published |
20140227230 | NON-ENTOMOPHILOUS TOMATO YELLOW LEAF CURL VIRUS | 2014-08-14 |
20140227231 | LAMININS, DERIVATIVES, AND COMPOSITIONS INCLUDING SAME AND METHODS FOR THEIR THERAPEUTIC USE | 2014-08-14 |
20140227232 | Methods and Compositions for Delivery of Exogenous Factors to Nervous System Sites | 2014-08-14 |
20140227234 | METHODS OF USING REGENERATIVE CELLS TO PROMOTE WOUND HEALING | 2014-08-14 |
20140227235 | CARTILAGE CELL TREATMENT COMPRISING COLLAGEN, HYALURONIC ACID DERIVATIVE, AND STEM CELL DERIVED FROM MAMMAL UMBILICAL CORD | 2014-08-14 |
20140227236 | HIV-RESISTANT STEM CELLS AND USES THEREOF | 2014-08-14 |
20140227237 | RNA ENGINEERED T CELLS FOR THE TREATMENT OF CANCER | 2014-08-14 |
20140227238 | PEPTIDES HAVING PROTECTIVE EFFECT TOWARDS THE INFLAMMATORY ACTIVITY OF PEPTIDE 31-43 OF A-GLIADIN IN CELIAC DISEASE | 2014-08-14 |
20140227239 | GROWTH HORMONE SECRETAGOGUE | 2014-08-14 |
20140227240 | Regeneration of Spinal Discs | 2014-08-14 |
20140227241 | SERUM FRACTION OF PLATELET-RICH FIBRIN | 2014-08-14 |
20140227242 | COMPOSITIONS CONTAINING NON-POLAR COMPOUNDS | 2014-08-14 |
20140227243 | PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS | 2014-08-14 |
20140227244 | COUPLING ENDONUCLEASES WITH END-PROCESSING ENZYMES DRIVES HIGH EFFICIENCY GENE DISRUPTION | 2014-08-14 |
20140227245 | Pharmaceutical Angiogenic Composition Including a MicroRNA-382 Activator | 2014-08-14 |
20140227246 | Pharmaceutical Anti-Angiogenic Composition Including a MicroRNA-382 Inhibitor | 2014-08-14 |
20140227247 | CHIMERIC NEUREGULINS AND METHOD OF MAKING AND USE THEREOF | 2014-08-14 |
20140227248 | COMPOSITIONS AND METHOD FOR INCREASING PRODUCTION OF RECOMBINANT GAMMA-CARBOXYLATED PROTEINS | 2014-08-14 |
20140227249 | SCREENING METHODS AND USES THEREOF | 2014-08-14 |
20140227250 | STABLE FORMULATIONS OF ANTIBODIES TO TSLP | 2014-08-14 |
20140227251 | METHODS FOR IDENTIFYING ANTIBODIES WITH REDUCED IMMUNOGENICITY | 2014-08-14 |
20140227252 | Methods and Monitoring of Treatment with a DLL4 Antagonist | 2014-08-14 |
20140227253 | Antigen Binding Molecules That Bind EGFR, Vectors Encoding Same, and Uses Thereof | 2014-08-14 |
20140227254 | ANTAGONISTS OF BMP9, BMP10, ALK1 AND OTHER ALK1 LIGANDS, AND USES THEREOF | 2014-08-14 |
20140227255 | COMBINATION THERAPY OF ANTI-HER3 ANTIBODIES | 2014-08-14 |
20140227256 | Predictive biomarker for cancer treatment with ADCC-enhanced antibodies | 2014-08-14 |
20140227257 | Monoclonal Antibodies that Neutralize Anthrax Protective Antigen (PA) Toxin | 2014-08-14 |
20140227258 | HUMANIZED ANTI-CMET ANTAGONISTS | 2014-08-14 |
20140227259 | MODIFIED PROTEINS AND PEPTIDES | 2014-08-14 |
20140227260 | AMINOPYRIMIDINE INHIBITORS OF TYROSINE KINASE | 2014-08-14 |
20140227261 | USE OF OMEGA FATTY ACIDS FOR TREATING DISEASE | 2014-08-14 |
20140227262 | PD-1 Antagonists and Methods for Treating Infectious Disease | 2014-08-14 |
20140227263 | USE OF FGFR1 EXTRA CELLULAR DOMAIN PROTEINS TO TREAT CANCERS CHARACTERIZED BY LIGAND-DEPENDENT ACTIVATING MUTATIONS IN FGFR2 | 2014-08-14 |
20140227264 | DRUG FUSIONS AND CONJUGATES WITH EXTENDED HALF LIFE | 2014-08-14 |
20140227265 | METHOD OF TREATING OR AMELIORATING METABOLIC DISORDERS USING CLEC-2 | 2014-08-14 |
20140227266 | NOGO Receptor Antagonists | 2014-08-14 |
20140227267 | BOVINE FUSION ANTIBODIES | 2014-08-14 |
20140227268 | AGENTS THAT ENGAGE ANTIGEN-PRESENTING CELLS THROUGH DENDRITIC CELL ASIALOGLYCOPROTEIN RECEPTOR (DC-ASGPR) | 2014-08-14 |
20140227269 | THERAPEUTIC NUCLEASE COMPOSITIONS AND METHODS | 2014-08-14 |
20140227270 | BISPECIFIC ANTI-CXCR7 IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS | 2014-08-14 |
20140227271 | SOMATIC MUTATIONS IN ATRX IN BRAIN CANCER | 2014-08-14 |
20140227272 | Anti-Leukocyte Adhesion for the Mitigation of Potential Adverse Events caused by CD3-Specific Binding Domains | 2014-08-14 |
20140227273 | MULTI-SPECIFIC BINDING MOLECULES TARGETING ABERRANT CELLS | 2014-08-14 |
20140227274 | Prevention and Treatment of Amyloidogenic Disease | 2014-08-14 |
20140227275 | METHODS OF TREATING AND DIAGNOSING PANCREATITIS | 2014-08-14 |
20140227276 | GPR177 AS TARGET AND MARKER IN TUMORS | 2014-08-14 |
20140227277 | Combination therapy with an anti-CD19 antibody and a purine analog | 2014-08-14 |
20140227278 | ANTIBODIES TO HUMAN SIGNAL PEPTIDE-CONTAINING PROTEINS | 2014-08-14 |
20140227279 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES | 2014-08-14 |
20140227280 | PROTEIN COMPLEX COMPRISING MCM8 AND MCM9 PROTEINS AND THEIR USE | 2014-08-14 |
20140227281 | Methods of Treating Herpesvirus Infections | 2014-08-14 |
20140227282 | THERAPEUTIC AGENT FOR PANCREATIC CANCER AND/OR BILIARY TRACT CANCER | 2014-08-14 |
20140227283 | ANTI-AXL ANTIBODIES AND USES THEREOF | 2014-08-14 |
20140227284 | SYNTHETIC LETHALITY AND THE TREATMENT OF CANCER | 2014-08-14 |
20140227285 | ANTI-PSEUDOMONAS PSL BINDING MOLECULES AND USES THEREOF | 2014-08-14 |
20140227286 | Annexin A2 as Immunological Target | 2014-08-14 |
20140227287 | NOVEL ANTI-HUMAN NGF ANTIBODY | 2014-08-14 |
20140227288 | PNMT AS A NOVEL MARKER FOR PROGENITOR CELLS | 2014-08-14 |
20140227289 | COMPOUNDS AND METHODS FOR TREATING INSULIN RESISTANCE SYNDROME | 2014-08-14 |
20140227290 | METHOD FOR INCREASING N-GLYCOSYLATION SITE OCCUPANCY ON THERAPEUTIC GLYCOPROTEINS PRODUCED IN PICHIA PASTORIS | 2014-08-14 |
20140227291 | AMYLOID-BETA BINDING PROTEINS | 2014-08-14 |
20140227292 | Anti-MCAM Antibodies And Associated Methods Of Use | 2014-08-14 |
20140227293 | METHOD FOR CONTROLLING TUMOR GROWTH, ANGIOGENESIS AND METASTASIS USING IMMUNOGLOBULIN CONTAINING AND PROLINE RICH RECEPTOR-1 (IGPR-1) | 2014-08-14 |
20140227294 | PROLACTIN RECEPTOR BINDING PROTEINS AND USES THEREOF | 2014-08-14 |
20140227295 | TUBULYSIN COMPOUNDS, METHODS OF MAKING AND USE | 2014-08-14 |
20140227296 | MODIFIED GLYCOLIPIDS AND METHODS OF MAKING AND USING THE SAME | 2014-08-14 |
20140227297 | TARGETED THERANOSTICS | 2014-08-14 |
20140227298 | TUBULYSIN COMPOUNDS, METHODS OF MAKING AND USE | 2014-08-14 |
20140227299 | NEMORUBICIN METABOLITE AND ANALOG REAGENTS, ANTIBODY-DRUG CONJUGATES AND METHODS | 2014-08-14 |
20140227300 | INHIBITION OF INNATE IMMUNE RESPONSE | 2014-08-14 |
20140227301 | IMMUNOGENIC COMPOSITIONS AGAINST HUMAN PROGASTRIN PEPTIDES | 2014-08-14 |
20140227302 | GAMMA SECRETASE INHIBITORS | 2014-08-14 |
20140227303 | METHODS FOR DIAGNOSING AND MONITORING DISEASES OR CONDITIONS USING DISEASE MODIFIED BIOMOLECULES AND MEASUREMENT OF A FUNCTIONAL IMMUNE RESPONSE | 2014-08-14 |
20140227304 | VACCINES FOR PREVENTING AND TREATING ALZHEIMER'S DISEASE | 2014-08-14 |
20140227305 | EPSTEIN-BARR-VIRUS VACCINE | 2014-08-14 |
20140227306 | MULTIMERIC MULTIEPITOPE POLYPEPTIDES IN IMPROVED SEASONAL AND PANDEMIC INFLUENZA VACCINES | 2014-08-14 |
20140227307 | VACCINES AGAINST HERPES SIMPLEX VIRUS TYPE 2: COMPOSITIONS AND METHODS FOR ELICITING AN IMMUNE RESPONSE | 2014-08-14 |
20140227308 | RECOMBINANT PROTEIN CARRYING HUMAN PAPILLOMAVIRUS EPITOPES INSERTED IN AN ADENYLATE CYCLASE PROTEIN OR FRAGMENT THEREOF THERAPEUTIC USES THEREOF | 2014-08-14 |
20140227309 | COMBINATION VACCINE FOR RESPIRATORY SYNCYTIAL VIRUS AND INFLUENZA | 2014-08-14 |
20140227310 | RECOMBINANT INFLUENZA VIRUS HIGHLY EXPRESSING HA PROTEIN AND PREPARATION METHOD AND USE THEREOF | 2014-08-14 |
20140227311 | Method for Removing Immunosuppressive Properties of HIV Envelope Glycoproteins | 2014-08-14 |
20140227312 | A1 MOIETY OF CHOLERA TOXIN A SUBUNIT AS AN ADJUVANT FOR MUCOSAL AND SYSTEMIC VACCINES | 2014-08-14 |
20140227313 | GROUP A STREPTOCOCCAL M-RELATED PROTEINS AND METHODS OF USE | 2014-08-14 |
20140227314 | Engineered Type IV Pilin of Clostridium difficile | 2014-08-14 |
20140227315 | Novel Chimeric Proteins and Methods for Using The Same | 2014-08-14 |
20140227316 | BETA-LACTAM COMPOUNDS FOR ENHANCING T CELL-MEDIATED IMMUNE RESPONSES | 2014-08-14 |
20140227317 | HETEROBIFUNCTIONAL LINKERS WITH POLYETHYLENE GLYCOL SEGMENTS AND IMMUNE RESPONSE MODIFIER CONJUGATES MADE THEREFROM | 2014-08-14 |
20140227318 | SLEEP QUALITY IMPROVING AGENT | 2014-08-14 |
20140227319 | SELECTING, PRODUCING, AND FEEDING WHOLE ALGAE AS A FEED SUPPLEMENT FOR CATTLE AND BISON TO PRODUCE MEAT HIGH IN OMEGA 3'S FOR HUMAN HEALTH | 2014-08-14 |
20140227320 | ANTI-VIRAL COMPOUNDS | 2014-08-14 |
20140227321 | ANTI-VIRAL COMPOUNDS | 2014-08-14 |
20140227322 | RABIES VIRUS LIKE PARTICLE PRODUCTION IN PLANTS | 2014-08-14 |
20140227323 | RECOMBINANT ADENYLATE CYCLASE TOXIN OF BORDETELLA INDUCES T CELL RESPONSES AGAINST TUMORAL ANTIGENS | 2014-08-14 |
20140227324 | USE OF AN IL12 RECEPTOR-BETA 1 SPLICE VARIANT TO DIAGNOSE ACTIVE TUBERCULOSIS | 2014-08-14 |
20140227325 | LIGNIN-DERIVED POROUS CARBON COMPOSITION, METHODS OF PREPARATION, AND USE THEREOF | 2014-08-14 |
20140227326 | METHOD OF DELIVERING NASAL SPRAY | 2014-08-14 |
20140227327 | Injectable Cryogel Vaccine Devices and Methods of Use Thereof | 2014-08-14 |
20140227328 | Delivery Particles | 2014-08-14 |
20140227329 | MICROCAPSULES HAVING AN ENVELOPE COMPOSED ESSENTIALLY OF SILSESQUIOXANE HOMOPOLYMERS OR COPOLYMERS | 2014-08-14 |
20140227330 | CAPSULE WHOSE ENVELOPE IS SEPARATELY IMPERCEPTIBLE DURING THE TOPICAL USE THEREOF | 2014-08-14 |